Search research articles
Contact Us
Filters
Showing results (31-40 of 70) with videos related to
Page
of 7
Sort By:
International Journal of Radiation Oncology, Biology, Physics
|
May 31, 2001
Influence of interfraction interval on the efficacy and toxicity of hyperfractionated radiotherapy in combination with concurrent daily chemotherapy in stage III non-small-cell lung cancer
Y Shibamoto, B Jeremic, L Acimovic, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1991
Radiotherapy of metastatic spinal cord compression
B Jeremic, D Grujicic, V Cirovic, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 1998
Absence of thoracic radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for Stage III nonsmall-cell lung cancer
B Jeremic, Y Shibamoto, B Milicic, et al.
American Journal of Clinical Oncology
|
October 1, 1995
Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II study
B Jeremic, D Grujicic, V Antunovic, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 1, 1992
Carboplatin and radiation therapy for stage IV carcinoma of the head and neck. Preliminary results of a phase II study
B Jeremic, D J Zivic, L J Djuric, et al.
Journal of Chromatography
|
May 13, 1988
Determination of eproxindine hydrochloride in human plasma by capillary gas chromatography
W Dahmen, W Gielsdorf, B Jeremic, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 8, 1997
Prolonged administration of oral etoposide alone or with intravenous carboplatin in stage IV non-small cell lung cancer: a randomized trial
B Jeremic, Y Shibamoto, L Acimovic, et al.
Journal of Chemotherapy (Florence, Italy)
|
April 1, 1992
Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas
B Jeremic, D Jovanovic, L J Djuric, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 30, 1998
Concurrent radiochemotherapy for patients with stage III non-small-cell lung cancer (NSCLC): long-term results of a phase II study
B Jeremic, Y Shibamoto, B Milicic, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 1994
Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study
B Jeremic, D Grujicic, V Antunovic, et al.
Page
of 7
Search research articles
Search
Showing results (31-40 of 70) with videos related to
Sort By:
Page
of 7
International Journal of Radiation Oncology, Biology, Physics
|
May 31, 2001
Influence of interfraction interval on the efficacy and toxicity of hyperfractionated radiotherapy in combination with concurrent daily chemotherapy in stage III non-small-cell lung cancer
Y Shibamoto, B Jeremic, L Acimovic, et al.
Acta Oncologica (Stockholm, Sweden)
|
January 1, 1991
Radiotherapy of metastatic spinal cord compression
B Jeremic, D Grujicic, V Cirovic, et al.
International Journal of Radiation Oncology, Biology, Physics
|
February 11, 1998
Absence of thoracic radiation myelitis after hyperfractionated radiation therapy with and without concurrent chemotherapy for Stage III nonsmall-cell lung cancer
B Jeremic, Y Shibamoto, B Milicic, et al.
American Journal of Clinical Oncology
|
October 1, 1995
Accelerated hyperfractionated radiation therapy for malignant glioma. A phase II study
B Jeremic, D Grujicic, V Antunovic, et al.
Journal of Chemotherapy (Florence, Italy)
|
June 1, 1992
Carboplatin and radiation therapy for stage IV carcinoma of the head and neck. Preliminary results of a phase II study
B Jeremic, D J Zivic, L J Djuric, et al.
Journal of Chromatography
|
May 13, 1988
Determination of eproxindine hydrochloride in human plasma by capillary gas chromatography
W Dahmen, W Gielsdorf, B Jeremic, et al.
Lung Cancer (Amsterdam, Netherlands)
|
October 8, 1997
Prolonged administration of oral etoposide alone or with intravenous carboplatin in stage IV non-small cell lung cancer: a randomized trial
B Jeremic, Y Shibamoto, L Acimovic, et al.
Journal of Chemotherapy (Florence, Italy)
|
April 1, 1992
Advantage of post-radiotherapy chemotherapy with CCNU, procarbazine, and vincristine (mPCV) over chemotherapy with VM-26 and CCNU for malignant gliomas
B Jeremic, D Jovanovic, L J Djuric, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 30, 1998
Concurrent radiochemotherapy for patients with stage III non-small-cell lung cancer (NSCLC): long-term results of a phase II study
B Jeremic, Y Shibamoto, B Milicic, et al.
International Journal of Radiation Oncology, Biology, Physics
|
December 1, 1994
Hyperfractionated radiation therapy (HFX RT) followed by multiagent chemotherapy (CHT) in patients with malignant glioma: a phase II study
B Jeremic, D Grujicic, V Antunovic, et al.
Page
of 7